ArticleVeterinary research communications2025
Protective effects of chlorogenic acid on hepatic injury in piglets challenged with lipopolysaccharide: a preliminary study.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Safe dosage and potential risks of chlorogenic acid: insights fromFrontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The liver of early weaned piglets is one of the most vulnerable organs to immunological stress. This study investigated the protective effects of chlorogenic acid (CGA) on the liver of weaned piglets subjected to immunological stress induced by lipopolysaccharide (LPS). The weaned piglets were fed with 1 g CGA/kg diet for 21 days prior to an i.p. injection of 100 µg LPS/kg body weight administration. The results showed that the LPS increased serum alanine aminotransferase activity and liver caspase 3 mRNA expression, which were reversed by CGA supplementation. CGA normalized hepatic interleukin (IL) 18 and IL1β at both the protein expression and mRNA abundance, myeloperoxidase activity and p65 mRNA expression in LPS-administrated piglets. Dietary CGA supplementation increased hepatic ATP, complex III and complex I contents in the LPS-challenged piglets. The upregulated hepatic optineurin and BCL2 interacting protein 3 like mRNA levels in the LPS-challenged piglets were normalized to control values when supplementing CGA. These data represent preliminary evidence that CGA attenuates hepatic injury, inflammation, and mitochondrial dysfunction in piglets challenged with LPS, indicating CGA could be a potential natural agent for alleviating liver injury and immunological stress in weaned piglets.
Indexed as
Identifiers
41240172What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.